TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More

Monday September 28, 2020 0 comments Tags: Westminster, TriSalus Life Sciences, SD-101, Mats Wahlstrom, Mary Szela, Steven Katz

TriSalus Life Sciences appoints Scott Davie chief technology officer

TriSalus Life Sciences appoints Scott Davie chief technology officer

DENVER -- TriSalus Life Sciences announced the appointment of Scott Davie to the role of chief technology officer, deepening the company’s leadership capabilities as it builds an integrated... Read More

Monday June 8, 2020 0 comments Tags: Denver, TriSalus Life Sciences, Scott Davie, Mary Szela

TriSalus Life Sciences launches TriNav Infusion System to overcome infusion barriers in tumors

TriSalus Life Sciences launches TriNav Infusion System to overcome infusion barriers in tumors

DENVER -- TriSalus Life Sciences announced the launch of its TriNav Infusion System. Powered by its proprietary Pressure-Enabled Drug DeliveryTM (PEDD) approach with SmartValveTM technology,... Read More

Thursday January 16, 2020 0 comments Tags: Denver, TriSalus Life Sciences, Mary Szela

TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer

TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer

WESTMINSTER -- A phase 1b clinical trial shows that administering a concentrated dose of anti-CEA CAR-T cells precisely at the site of a solid tumor by means of TriSalusLife Sciences unique... Read More

Wednesday November 7, 2018 0 comments Tags: Westminster, TriSalus Life Sciences, Sorrento Therapeutics, Mary Szela, Surefire Medical

TriSalus Life Sciences names Daniel Estay chief business officer

TriSalus Life Sciences names Daniel Estay chief business officer

DENVER -- TriSalus Life Sciences announced the appointment of Daniel Estay as its chief business officer, reporting to the companys chief executive officer, Mary Szela . TriSalus (formerly... Read More

Monday September 24, 2018 0 comments Tags: Denver, TriSalus Life Sciences, Daniel Estay, Mary Szela, Surefire Medical